Your browser doesn't support javascript.
loading
TRIM56 is an essential component of the TLR3 antiviral signaling pathway.
Shen, Yang; Li, Nan L; Wang, Jie; Liu, Baoming; Lester, Sandra; Li, Kui.
Afiliação
  • Shen Y; Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
J Biol Chem ; 287(43): 36404-13, 2012 Oct 19.
Article em En | MEDLINE | ID: mdl-22948160
ABSTRACT
Members of the tripartite motif (TRIM) proteins are being recognized as important regulators of host innate immunity. However, specific TRIMs that contribute to TLR3-mediated antiviral defense have not been identified. We show here that TRIM56 is a positive regulator of TLR3 signaling. Overexpression of TRIM56 substantially potentiated extracellular dsRNA-induced expression of interferon (IFN)-ß and interferon-stimulated genes (ISGs), while knockdown of TRIM56 greatly impaired activation of IRF3, induction of IFN-ß and ISGs, and establishment of an antiviral state by TLR3 ligand and severely compromised TLR3-mediated chemokine induction following infection by hepatitis C virus. The ability to promote TLR3 signaling was independent of the E3 ubiquitin ligase activity of TRIM56. Rather, it correlated with a physical interaction between TRIM56 and TRIF. Deletion of the C-terminal portion of TRIM56 abrogated the TRIM56-TRIF interaction as well as the augmentation of TLR3-mediated IFN response. Together, our data demonstrate TRIM56 is an essential component of the TLR3 antiviral signaling pathway and reveal a novel role for TRIM56 in innate antiviral immunity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Hepatite C / Hepacivirus / Ubiquitina-Proteína Ligases / Receptor 3 Toll-Like / Imunidade Inata Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Hepatite C / Hepacivirus / Ubiquitina-Proteína Ligases / Receptor 3 Toll-Like / Imunidade Inata Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article